Devyser Diagnostics AB (publ) announced that at the Annual General Meeting held on 14 May 2024 Thomas Eklund was elected as new member of the Board of Directors for the same period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111 SEK | -0.45% | +7.77% | +41.22% |
05-30 | Devyser Wins Tender for Oncology NGS Solutions in Italy | CI |
05-27 | Devyser Wins Tender for Thalassemia in Italy | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.22% | 173M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.19% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- DVYSR Stock
- News Devyser Diagnostics AB
- Devyser Diagnostics AB Appoints Thomas Eklund as Member of the Board of Directors